AI assistant
ASP Isotopes Inc. — Director's Dealing 2025
Apr 18, 2025
32264_dirs_2025-04-17_90ee076d-7943-45c4-a996-373aa25a17cd.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ASP Isotopes Inc. (ASPI)
CIK: 0001921865
Period of Report: 2025-04-15-05:00
Reporting Person: Ainscow Robert (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-04-15-05:00 | Common Stock | S | 66666 | $5.7535 | Disposed | 1553326 | Direct |
| 2025-04-16-05:00 | Common Stock | S | 66666 | $5.4454 | Disposed | 1486660 | Direct |
| 2025-04-17-05:00 | Common Stock | S | 66668 | $5.6213 | Disposed | 1419992 | Direct |
Footnotes
F1: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Robert Ainscow dated December 13, 2024.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.48 to $6.70, inclusive. The reporting person undertakes to provide ASP Isotopes Inc. (the "Company"), any stockholder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnote 2.
F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.26 to $5.70, inclusive. The reporting person undertakes to provide the Company, any stockholder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnote 3.
F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.25 to $6.02, inclusive. The reporting person undertakes to provide the Company, any stockholder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnote 4.